Hong Kong · Delayed Price · Currency is HKD Luye Pharma Group Statistics
Total Valuation
HKG:2186 has a market cap or net worth of HKD 6.31 billion. The enterprise value is 10.03 billion.
| Market Cap | 6.31B |
| Enterprise Value | 10.03B |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2186 has 3.99 billion shares outstanding. The number of shares has increased by 6.66% in one year.
| Current Share Class | 3.99B |
| Shares Outstanding | 3.99B |
| Shares Change (YoY) | +6.66% |
| Shares Change (QoQ) | -0.88% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 21.93% |
| Float | 2.20B |
Valuation Ratios
The trailing PE ratio is 7.89 and the forward PE ratio is 8.16.
| PE Ratio | 7.89 |
| Forward PE | 8.16 |
| PS Ratio | 0.96 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.32 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.05 |
| EV / Sales | 1.48 |
| EV / EBITDA | 4.57 |
| EV / EBIT | 8.03 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.45 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 5.92 |
| Debt / FCF | n/a |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is 4.27% and return on invested capital (ROIC) is 4.51%.
| Return on Equity (ROE) | 4.27% |
| Return on Assets (ROA) | 2.18% |
| Return on Invested Capital (ROIC) | 4.51% |
| Return on Capital Employed (ROCE) | 5.24% |
| Weighted Average Cost of Capital (WACC) | 5.62% |
| Revenue Per Employee | 1.34M |
| Profits Per Employee | 152,547 |
| Employee Count | 5,270 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, HKG:2186 has paid 315.55 million in taxes.
| Income Tax | 315.55M |
| Effective Tax Rate | 27.27% |
Stock Price Statistics
The stock price has decreased by -51.23% in the last 52 weeks. The beta is 0.87, so HKG:2186's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -51.23% |
| 50-Day Moving Average | 1.88 |
| 200-Day Moving Average | 2.29 |
| Relative Strength Index (RSI) | 29.99 |
| Average Volume (20 Days) | 19,450,140 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2186 had revenue of HKD 7.08 billion and earned 803.92 million in profits. Earnings per share was 0.20.
| Revenue | 7.08B |
| Gross Profit | 4.51B |
| Operating Income | 1.35B |
| Pretax Income | 1.16B |
| Net Income | 803.92M |
| EBITDA | 2.29B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 12.43 billion in cash and 13.84 billion in debt, with a net cash position of -1.41 billion or -0.35 per share.
| Cash & Cash Equivalents | 12.43B |
| Total Debt | 13.84B |
| Net Cash | -1.41B |
| Net Cash Per Share | -0.35 |
| Equity (Book Value) | 20.29B |
| Book Value Per Share | 4.50 |
| Working Capital | 6.60B |
Cash Flow
In the last 12 months, operating cash flow was 508.22 million and capital expenditures -590.39 million, giving a free cash flow of -82.17 million.
| Operating Cash Flow | 508.22M |
| Capital Expenditures | -590.39M |
| Depreciation & Amortization | 957.45M |
| Net Borrowing | 1.53B |
| Free Cash Flow | -82.17M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 63.75%, with operating and profit margins of 19.04% and 11.36%.
| Gross Margin | 63.75% |
| Operating Margin | 19.04% |
| Pretax Margin | 16.35% |
| Profit Margin | 11.36% |
| EBITDA Margin | 32.33% |
| EBIT Margin | 19.04% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2186 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.66% |
| Shareholder Yield | -6.66% |
| Earnings Yield | 12.68% |
| FCF Yield | -1.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:2186 is 2.83, which is 79.11% higher than the current price. The consensus rating is "Buy".
| Price Target | 2.83 |
| Price Target Difference | 79.11% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 3.86% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2186 has an Altman Z-Score of 1.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 5 |